The following post is by HIVMA Executive Director Andrea Weddle, reporting from the International AIDS Conference in Vienna. “There’s no separate science for the rich and poor. The research applies to both,” said Dr. Peter Mugyenyi when asked whether “when to start to HIV treatment” was a real question for Uganda and countries in sub-Saharan […]
Vienna — “Slow, timid, and uncoordinated.” Those were the words Tony Harries, Senior Adviser to the International Union Against Tuberculosis and Lung Disease, used to describe the response to deadly HIV/TB co-infection, with its 40 percent mortality. Harries opened the session of TB and HV Management in High-Prevalence Settings Wednesday morning at the 18th International […]
During a press conference Tuesday at the International AIDS Conference in Vienna, Anthony Fauci, MD, Director of the National Institute of Allergy and Infectious Diseases at NIH, describes the Vaginal and Oral Interventions to Control the Epidemic (VOICE) trial. The study is testing the safety and efficacy of microbicide gel containing the ARV drug tenofovir, […]
HIV
Amid unprecedented challenges to routine healthcare access, trial results mark a first for a critically needed HIV prevention measure An investigational drug administered by injection every […]
Tuberculosis
In the six weeks before South Africa responded its first diagnoses of COVID-19 with the start of physical distancing measures, more than 47,000 people on average […]
Research & Development
What we have learned from HIV can guide responses to COVID-19 that are innovative, effective and inclusive, and can help end the pandemic faster The following […]
Policy
The following is a guest post by Kenneth G. Castro, MD, FIDSA Since its formation in 1948, WHO has relied heavily on the U.S. for collaborations […]